No Prescription |
 |
 | ||
|
Atacand Plus Atacand |
|
| ||
No Prescription » Prescription Drugs 2 » Atacand Plus Atacand Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Atacand plus is indicated in the treatment of Hypertension. This fixed dose is not indicated for initial therapy. Candesartan (kan-de-SAR-tan) belongs to the class of medicines called angiotensin II inhibitors. It is used to treat high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time the heart and arteries may not function properly. This can damage the blood vessels of the brain heart and kidneys resulting in a stroke heart failure or kidney failure. High blood pressure may also increase the risk of heart attacks. These problems may be less likely to occur if blood pressure is controlled. Candesartan works by blocking the action of a substance in the body that causes blood vessels to tighten. As a result candesartan relaxes blood vessels. This lowers blood pressure. Hydrochlorothiazide is a thiazide diuretic (water pill) that helps prevent your body from absorbing too much salt which can cause fluid retention. Hydrochlorothiazide treats fluid retention (edema) in people with congestive heart failure cirrhosis of the liver or kidney disorders or edema caused by taking steroids or estrogen. This medication is also used to treat high blood pressure (hypertension). Buy Atacand Plus Atacand and other Prescription Drugs 2 products online at Medstore. 3636
About Atacand Plus Atacand: Product Type: Prescription Drugs 2 Atacand Plus ( Atacand Generic Candesartan & Hydrochlorothiazide ) Atacand Plus (Atacand Generic Candesartan & Hydrochlorothiazide) Atacand Generic Candesartan & Hydrochlorothiazide 16/12.5mg 28 Tablets Atacand Generic Candesartan & Hydrochlorothiazide Atacand Plus
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
